Content uploaded by Judith A Johnson
Author content
All content in this area was uploaded by Judith A Johnson on Feb 02, 2015
Content may be subject to copyright.
INFECTION
AND
IMMUNITY,
May
1994,
p.
2108-2110
0019-9567/94/$04.00+0
Copyright
©
1994,
American
Society
for
Microbiology
Vibrio
cholerae
0139
Synonym
Bengal
Is
Closely
Related
to
Vibrio
cholerae
El
Tor
but
Has
Important
Differences
JUDITH
A.
JOHNSON,l12.3*
CARLOS
A.
SALLES,4
PINAKI
PANIGRAHI,
1'35
M.
JOHN
ALBERT
6
ANITA
C.
WRIGHT,3
ROBERT
J.
JOHNSON,1'2
AND
J.
GLENN
MORRIS,
JR.1'3
Veterans
Administration
Medical
Center
of
Baltimore'
and
Department
of
Pathology,2
Department
of
Medicine
and
Center
for
Vaccine
Development,3
and
Department
of
Pediatrics,5
University
of
Maryland
at
Baltimore,
Baltimore,
Matyland
21201;
Department
of
Biochemistry
and
Molecular
Biology,
Instituto
Oswaldo
Cruz,
FIOCRUZ,
Rio
de
Janeiro,
Brazil4;
and
Department
of
Laboratory
Research,
Laboratory
Sciences
Division,
International
Centre
for
Diarrhoeal
Diseases
Research,
Bangladesh,
Dhaka,
Bangladesh6
Received
29
November
1993/Returned
for
modification
19
January
1994/Accepted
1
February
1994
Although
Vibrio
cholerae
0139
synonym
Bengal
strains,
from
the
current
epidemics
in
India
and
Bangladesh,
are
closely
related
to
seventh-pandemic
strains,
as
shown
by
multilocus
enzyme
electrophoresis,
Bengal
strains
are
encapsulated
and
portions
of
the
01
antigen
biosynthetic
complex
genes
found
in
01
strains
are
altered
or
lacking.
Encapsulated
Bengal
strains
showed
resistance
to
killing
by
normal
human
serum.
The
presence
of
the
capsule
suggests
the
potential
for
bloodstream
invasion
in
susceptible
hosts
and
has
profound
implications
for
vaccine
development.
Vibrio
cholerae
strains
of
0
group
1
(01
strains)
have
traditionally
been
classified
as
the
etiologic
agent
for
cholera,
a
well-recognized
cause
of
morbidity
and
mortality
throughout
the
world:
to
date
there
have
been
seven
recorded
pandemics
of
this
severe
dehydrating
diarrheal
disease.
V.
cholerae
of
0
groups
other
than
1
(non-O1,
or
nonagglutinating,
V
cholerae)
can
also
cause
gastrointestinal
disease
(6)
as'
well
as
extrain-
testinal
infections
such
as
wound
infections
and
septicemia
(9).
Until
recently
it
was
believed
that
only
01
strains
had
epidemic
potential,
with
isolation
of
non-O1
strains
being
restricted
to
sporadic
cases.
Late
in
1992,
large
outbreaks
of
cholera-like
disease
occurred
in
southern
and
eastern
India
and
southern
Bangladesh
(1),
with
subsequent
spread
into
other
parts
of
Asia.
The
causative
agent
was
a
toxigenic
strain
of
the
previ-
ously
unidentified
serovar
0139
(V
cholerae
0139
synonym
Bengal);
these
strains
did
not
agglutinate
with
either
poly-
clonal
or
monoclonal
antisera
directed
against
the
V.
cholerae
01
antigen.
In
the
Bangladeshi
studies,
the
incidence
of
disease
was
as
high
in
adults
as
in
children,
suggesting
that
prior
immunity
to
V
cholerae
01
El
Tor
was
not
protective
against
0139
infection
(1).
The
appearance
of
epidemic
non-O1
disease
raises
basic
questions
about
the
degree
of
relatedness
between
0139
iso-
lates
and
epidemic
01
strains:
do
0139
strains
represent
a
simple
mutation
altering
the
0
antigen
of
the
current
pandemic
El
Tor
strain,
as
has
been
proposed
by
Hall
et
al.
(1)?;
are
they
a
distantly
related
non-O1
strain
(with
non-O1
characteristics,
such
as
encapsulation
[5])
that
has
acquired
virulence
factors?;
or
do
they
lie
somewhere
between
these
extremes?
An
under-
standing
of
these
relationships
is
critical
as
we
begin
to
design
vaccines
which
may
be
effective
against
what
appears
to
be
the
etiologic
agent
of
the
eighth
cholera
pandemic.
To
assess
the
phylogenetic
relationship
between
Bengal
strains
and
other
V
cholerae,
we
analyzed
three
Bengal
strains
from
the
Bangladeshi
epidemic
(strains
A11837,
A11841,
and
A11852)
by
multilocus
enzyme
electrophoresis.
These
strains,
*
Corresponding
author.
Mailing
address:
Molecular
Diagnostics
Laboratory,
VAMC
Baltimore,
Room
4D-148,
10
N.
Greene
St.,
Baltimore,
MD
21201.
Phone:
(410)
605-7000,
ext.
5338.
Fax:
(410)
605-7911.
and
control
strains
from
our
collection
of
V
cholerae,
were
confirmed
to
be
V
cholerae
by
API
20E,
with
the
presence
of
cholera
toxin
genes
confirmed
by
using
CTAP,
a
23-base
alkaline
phosphatase-labeled
oligonucleotide
probe
developed
in
our
laboratory
(12).
In
the
enzyme
electrophoretic
typing
system
previously
described
by
Salles
and
colleagues
(10),
all
three
0139
strains
were
classified
as
being
in
zymovar
14.
V
cholerae
01
El
Tor
isolated
during
the
seventh
pandemic
in
Asia
and
01
El
Tor
strains
from
the
recent
South
American
epidemics
are
also
classified
as
zymovar
14
in
this
system.
Epidemic
V.
cholerae
01
strains
having
a
classical
biotype
belong
to
zymovar
13.
The
El
Tor
strain
endemic
to
the
U.S.
Gulf
Coast
forms
a
third
zymovar,
71,
which
differs
in
one
locus
from
14.
Environmental,
nontoxigenic
01
strains
are
generally
not
closely
related
to
epidemic
strains.
Other
non-O1
strains
occupy
over
100
zymovars,
with
a
species
diversity
which
approaches
that
seen
in
Escherichia
coli.
Our
zymovar
data
confirm
previous
reports
suggesting
that
Bengal
strains
are
very
closely
related
to
epidemic
V
cholerae
01
El
Tor.
0139
isolates
do
not
react
with
polyclonal
Inaba-
or
Ogawa-
specific
sera
or
monoclonal
antibodies
specific
for
A,
B,
and
C
antigens,
suggesting
that
the
01-antigen
may
be
missing
or
altered.
The
change
is
not
simply
loss
of
the
0
antigen,
as
0139
strains
are
typeable
and
virulent
and
do
not
produce
rough
colonies.
However,
small
changes
in
the
structure
of
the
0-specific
carbohydrate
might
be
sufficient
to
change
its
anti-
genicity.
To
further
examine
this
question,
eight
strains
(AI1837,
A11838,
A11841,
A11852,
A11854,
A11855,
A14260,
and
A14450)
from
the
Bangladeshi
epidemic,
E.
coli
DH5cx,
and
a
collection
of
01
and
non-O1
V
cholerae
strains
were
probed
for
rJbR
and
rfbS,
the
two
penultimate
genes
in
the
01
antigen
synthesis
operon.
A
region
encoding
01
antigen
biosynthesis
has
been
cloned
and
sequenced
for
El
Tor
and
classical
biotype
strains
(11).
Probes
O1SAP
(GGATTGGT
CACTTGATACCGC)
and
O1RAP
(GGTGAACGCTCTT
GCTACAGC),
specific
for
rJbS
and
rflR,
respectively,
were
derived
from
this
sequence
information,
and
alkaline
phos-
phatase
was
attached
to
a
5'
amino
nucleotide.
Strains
were
grown
overnight
on
L
agar,
and
colony
blots
were
prepared
on
Whatman
541
filters
and
hybridized
with
the
probes.
Both
01
antigen
probes
hybridized
with
40
strains
of
01
V
cholerae,
2108
Vol.
62,
No.
5
NOTES
2109
FIG.
1.
Polycationic
ferritin-stained
thin
sections
of
AI1855.
Magnification
x
38,000.
including
El
Tor
and
classical
biotypes
of
both
Inaba
and
Ogawa
serotypes.
In
contrast,
O1RAP
and
OISAP
failed
to
hybridize
with
the
eight
V.
cholerae
Bengal
strains
or
40
other
non-O1
strains,
including
three
cholera
toxin-producing
strains,
suggesting
that
at
least
two
genes
in
the
biosynthetic
pathway
for
the
01
antigen
are
missing
or
altered.
Further
studies
are
clearly
needed
to
define
the
genetic
relationship
between
the
01
and
0139
antigen
biosynthetic
pathways,
particularly
in
light
of
the
apparent
close
genetic
relationship
between
these
two
serovars.
As
we
have
previously
reported,
a
majority
of
non-01
V.
cholerae
strains
are
able
to
produce
a
polysaccharide
capsule
(4,
5).
Strains
are
able
to
shift
between
an
encapsulated
form
with
an
opaque
colonial
morphology
and
an
unencapsulated
or
minimally
encapsulated
form
with
a
translucent
colonial
mor-
phology;
the
degree
of
opacity
correlates
with
the
amount
of
capsular
material
which
can
be
extracted
from
the
cells
(4).
Encapsulation
is
associated
with
resistance
to
the
bactericidal
activity
of
normal
human
serum
and
with
increased
virulence
in
animal
models
(5).
It
has
been
hypothesized
that
the
ability
of
non-01
strains
to
cause
invasive
disease
is
related
to
capsule
expression.
V.
cholerae
01
is
not
similarly
encapsulated
and,
with
very
rare
exceptions,
is
not
invasive.
To
determine
whether
Bengal
strains
shared
the
ability
of
other
non-01
strains
to
express
a
capsule,
overnight
cultures
on
L
agar
were
evaluated
visually
for
opaque
versus
translucent
colony
morphology
and
phase
shifting.
All
eight
0139
strains
had
a
moderately
opaque
colony
morphology
on
initial
streaks;
translucent
sectors
and
colonies
appeared
after
subculturing.
Similar
changes
in
colony
morphology
were
not
seen
when
more
than
100
01
strains
from
clinical
and
environmental
sources
were
examined.
Two
Bengal
strains
(AI1855
and
A11841)
were
prepared
by
standard
methods,
stained
with
polycationic
fer-
ritin,
thin
sectioned
and
examined
by
electron
microscopy
(5).
Both
were
surrounded
by
a
relatively
thin
electron-dense
cap-
sule
(the
photomicrograph
for
strain
Al
1855
is
shown
in
Fig.
1).
Capsular
material,
extracted
and
purified
as
previously
de-
scribed
(8),
was
identified
as
an
animo
sugar-containing
polysac-
charide
by
high-performance
anion-exchange
chromatography
and
magnetic
nuclear
resonance
analysis
(la).
The
50%
lethal
dose
(LD5,,)
after
intradermal
injection
in
mice
was
only
marginally
lower
for
Bengal
strains
than
for
V.
cholerae
01
El
Tor
Ogawa
N16961,
a
highly
virulent
clinical
strain
used
extensively
in
prior
volunteer
studies
(LD50s,
1.5
x
10'
[geometric
mean
of
the
LD50s
of
three
0139
strains]
versus
5
x
10'
[strain
N16961]).
However,
in
contrast
to
findings
with
both
classical
and
El
Tor
01
strains,
which
were
not
isolated
from
blood,
V.
cholerae
could
be
isolated
from
the
blood
of
VOL.
62,
1994
I
2110
NOTES
mice
given
high
doses
of
0139
or
control
encapsulated
non-01
strains.
The
improved
ability
of
0139
isolates
to
survive
in
the
blood
may
be
due
to
increased
resistance
to
complement-mediated
killing.
Like
other
encapsulated
non-01
strains
(5),
Bengal
isolates
showed
a
drop
in
viable
counts
of
less
than
1.5
log1o
following
a
30-min
incubation
in
65%
normal
human
serum,
compared
with
a
circa
5-log
drop
for
classical
or
El
Tor
01
strains.
There
has
already
been
one
case
report
of
septicemia
due
to
an
0139
strain
(3);
in
keeping
with
observations
with
other
non-01
isolates
(9),
sepsis
occurred
in
a
patient
with
underly-
ing
liver
disease.
The
0139
strains
which
we
have
examined
do
not
have
the
thick
capsules
usually
associated
with
non-01
V.
cholerae
blood
isolates
(4),
suggesting
that
the
risk
of
dissem-
inated
disease
in
infected
persons
is
relatively
low.
Nonethe-
less,
these
observations
indicate
that
disseminated
disease
can
occur;
if
0139
strains
follow
the
pattern
of other
non-01
strains,
the
risk
of
dissemination
will
be
greatest
in
persons
with
chronic
underlying
illnesses
(9).
This
risk
raises
theoreti-
cal
questions
about
the
advisability
of
administering
oral
attenuated
vaccines
that
still
carry
the
capsule
to
persons
who
may
have
underlying
illnesses.
The
presence
of
the
capsule
may
also
have
an
effect
on
antigen
recognition:
in
volunteer
studies
with
other
non-01
strains,
the
presence
of
a
capsule
appeared
to
mask
certain
critical
surface
antigens,
with
a
resulting
decrease
in
host
immunologic
response
(7).
The
presence
of
a
capsule
and
the
apparent
absence
of
some
01
biosynthetic
genes
suggest
that
the
appearance
of
0139
strains
is
due
to
more
than
a
simple
point
mutation
in
the
0-antigen
biosynthetic
complex.
Further
work
is
needed
to
determine
whether
these
are
the
only
significant
genetic
and
phenotypic
differences
and
what
role
these
differences,
espe-
cially
the
presence
of
the
capsule
on
Bengal
strains,
play
in
pathogenesis
and
the
immune
response
elicited
by
these
isolates.
REFERENCES
1.
Albert,
M.
J.,
M.
Ansaruzzaman,
P.
K.
Bardhan,
A.
S.
G.
Faruque,
S.
M.
Faruque,
M.
S.
Islam,
D.
Mahalanabis,
R.
B.
Sack,
M.
A.
Salam,
A.
K.
Siddique,
M.
D.
Yunus,
and
K.
Zaman.
1993.
Large
epidemic
of
cholera-like
disease
in
Bangladesh
caused
by
Vibrio
cholerae
0139
synonym
Bengal.
Lancet
342:387-390.
(Let-
ter.)
la.Bush,
C.
A.,
and
C.
P.
Reddy.
Unpublished
data.
2.
Hall,
R.
H.,
F.
M.
Khambaty,
M.
Kothary,
and
S.
P.
Keasler.
1993.
Non-01
1ibrio
cholerae.
Lancet
342:430.
(Letter.)
3.
Jesudason,
M.
V.,
A.
M.
Cherian,
and
T.
J.
John.
1993.
Blood
stream
invasion
by
Vibrio
cholerae
0139.
Lancet
342:431.
(Letter.)
4.
Johnson,
J.
A.,
A.
Joseph,
P.
Panigrahi,
and
J.
G.
Morris,
Jr.
1992.
Frequency
of
encapsulated
versus
unencapsulated
strains
of
non-01
Vibrio
cholerae
from
patients
with
septicemia
or
diarrhea,
or
from
environmental
sources,
abstr.
B-277.
Abstr.
92nd
Annu.
Meet.
Am.
Soc.
Microbiol.
1992.
5.
Johnson,
J.
A.,
P.
Panigrahi,
and
J.
G.
Morris,
Jr.
1992.
Non-01
Vibrio
cholerae
NRT36S
produces
a
polysaccharide
capsule
that
determines
colony
morphology,
serum
resistance,
and
virulence
in
mice.
Infect.
Immun.
60:864-869.
6.
Morris,
J.
G.,
Jr.,
T.
Takeda,
B.
D.
Tall,
G.
A.
Losonsky,
S.
K.
Bhattacharya,
B.
D.
Forrest,
B.
A.
Kay,
and
M.
Nishibuchi.
1990.
Experimental
non-0
group
1
Vibrio
cholerae
gastroenteritis
in
humans.
J.
Clin.
Invest.
85:697-705.
7.
Panigrahi,
P.,
S.
Srinivas,
J.
A.
Johnson,
and
L.
J.
DeTolla.
1992.
Modulation
of
immunity
in
non-01
Vibrio
cholerae,
abstr.
B-316.
Abstr.
92nd
Annu.
Meet.
Am.
Soc.
Microbiol.
1992.
8.
Reddy,
G.
P.,
U.
Hayat,
C.
Abeygunawardana,
C.
Fox,
A.
C.
Wright,
D.
E.
Maneval,
C.
A.
Bush,
and
J.
G.
Morris,
Jr.
1992.
Purification
and
structure
determination
of
Vibnio
vulnificus
cap-
sular
polysaccharide.
J.
Bacteriol.
174:2620-2630.
9.
Safrin,
S.,
J.
G.
Morris,
M.
Adams,
V.
Pons,
R.
Jacobs,
and
J.
E.
Conte.
1987.
Non-01
Vibrio
cholerae
bacteremia:
a
case
report
and
review.
Rev.
Infect.
Dis.
10:1012-1017.
10.
Salles,
C.
A.,
and
H.
Momen.
1991.
Identification
of
Vibrio
cholerae
by
enzyme
electrophoresis.
Trans.
R.
Soc.
Trop.
Med.
Hyg.
85:544-547.
11.
Stroeher,
U.
W.,
L.
E.
Karageorgos,
R.
Morona,
and
P.
A.
Manning.
1992.
Serotype
conversion
in
Vibrio
cholerae
01.
Proc.
Nat.
Acad.
Sci.
USA
89:2566-2570.
12.
Wright,
A.
C.,
Y.
Guo,
J.
A.
Johnson,
J.
P.
Nataro,
and
J.
G.
Morris,
Jr.
1992.
Development
and
testing
of
a
nonradioactive
DNA
oligonucleotide
probe
that
is
specific
for
Vibrio
cholerae
cholera
toxin.
J.
Clin.
Microbiol.
30:2302-2306.
INFECT.
IMMUN.